Aqua Pharmaceuticals, an Almirall Company
Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees
Aqua Pharmaceuticals is a mid-sized specialty dermatology company focused on acquiring, developing, and marketing prescription medical dermatology products in the United States. Its current marketed lineup includes ACTICLATE, a doxycycline formulation; CORDRAN, available as a lotion, cream, and ointment; FLUOROPLEX, a 1% topical fluorouracil; XOLEGEL, a ketoconazole gel; VERDESO, desonide foam; and MONODOX, doxycycline monohydrate capsules. The firm aims for growth beyond its current lineup through product development, licensing, acquisitions, joint marketing arrangements, and partnerships. Aqua operates as part of Almirall and is based in Exton, Pennsylvania. Almirall, founded in 1943 and headquartered in Barcelona, completed the acquisition of Aqua Pharmaceuticals in 2013. The parent company's focus on dermatology and its practice of pursuing external collaborations shapes Aqua's role within the broader pharmaceutical landscape.